newsfilter
← Latest News
Business Wire·

AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer

ANGO
  • AngioDynamics, Inc. appointed Eric Honroth as President and Chief Executive Officer effective November 2, 2026.
  • Honroth joins the Board of Directors to succeed Jim Clemmer, who will depart the Board on the same date.
  • Clemmer served as CEO for ten years & will remain in a consulting capacity to ensure a smooth transition.
  • Honroth possesses over 20 years of leadership experience in cardiovascular, endovascular, urology, & oncology markets.
  • His prior senior roles include positions at Abbott Vascular, Becton Dickinson, CareFusion, Boston Scientific, & Getinge.
  • Most recently, Honroth served as Global President, Life Science at Getinge, where he led the $1.2 billion North American business.
  • The Board prioritized a leader with medical technology experience & a track record of commercial execution & operational discipline.
  • Board Chair Howard Donnelly cited Honroth's ability to build businesses, drive profitable growth, & manage global operations.
  • AngioDynamics currently maintains a strong balance sheet with no outstanding debt & is executing an operational transformation.
  • Clemmer credited his decade of leadership for sharpening the company's focus & positioning the business for future growth.
  • Honroth plans to leverage the company's differentiated technology portfolio & talented team to accelerate patient care & shareholder value.